Diabetes Type II Clinical Trial
To determine the predicting factors and indicators of compliance with insulin treatment in Diabetes Type II patients.
Status | Not yet recruiting |
Enrollment | 100 |
Est. completion date | December 2014 |
Est. primary completion date | August 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 35 Years to 70 Years |
Eligibility |
Inclusion Criteria: - With complete cognitive abilities - Independent functioning - Take insulin Exclusion Criteria: - Critically ill patients - Psychiatric patients |
Observational Model: Case-Only, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Hillel Yaffe Medical Center |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Insulin adherence | Average number of positive responses on the questionnaire scale | Forty minutes | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01713764 -
A Pilot Study of the Effects of Diet and Behavioral Interventions on Health in Diabetics
|
Phase 2 | |
Completed |
NCT01121315 -
A Retrospective Study of Cardiovascular Events Related to the Use of Glucose Lowering Drug Treatment in Primary Care
|
N/A | |
Completed |
NCT02773095 -
Evaluation of Novartis Access; a Non-communicable Disease (NCD) Access Initiative
|
N/A | |
Completed |
NCT02184455 -
Feasibility Study of DermGEN for Diabetic Foot Ulcer Treatment
|
Phase 1 | |
Recruiting |
NCT02361489 -
Clinical Study to Compare Various Dosing and Titration Guidelines of Insulin Delivered Via V-Go ® in Patients With Type 2 Diabetes Initiating Basal Bolus Therapy in Primary Care Offices
|
Phase 4 | |
Completed |
NCT02326129 -
Novel Biomarker for Development of T2D
|